Estimating 2-year risk of first relapse in ANCA-associated vasculitis: derivation of a risk-prediction model based on participants in the PEXIVAS trial.

Rituxan (rituximab) - Roche

cyclophosphamide - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/42772989

; Christian Pagnoux; David Jayne; David Massicotte-Azarniouch; Eswari Vilayur; Louis Girard; Mats Junek; Michael Walsh; Nader Khalidi; Peter A Merkel; Quazi Ibrahim; Ron Wald; Todd Fairhead

Sep 23, 2026